Annual EBITDA
-$35.53 M
+$3.15 M+8.15%
December 31, 2022
Summary
- As of February 11, 2025, BTTX annual EBITDA is -$35.53 million, with the most recent change of +$3.15 million (+8.15%) on December 31, 2022.
- During the last 3 years, BTTX annual EBITDA has fallen by -$29.83 million (-523.28%).
- BTTX annual EBITDA is now -523.28% below its all-time high of -$5.70 million, reached on December 31, 2019.
Performance
BTTX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$4.50 M
+$1.73 M+27.75%
September 30, 2023
Summary
- As of February 11, 2025, BTTX quarterly EBITDA is -$4.50 million, with the most recent change of +$1.73 million (+27.75%) on September 30, 2023.
- Over the past year, BTTX quarterly EBITDA has increased by +$5.80 million (+56.32%).
- BTTX quarterly EBITDA is now -343.35% below its all-time high of -$1.01 million, reached on June 30, 2020.
Performance
BTTX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$26.50 M
+$5.80 M+17.96%
September 30, 2023
Summary
- As of February 11, 2025, BTTX TTM EBITDA is -$26.50 million, with the most recent change of +$5.80 million (+17.96%) on September 30, 2023.
- Over the past year, BTTX TTM EBITDA has increased by +$14.60 million (+35.52%).
- BTTX TTM EBITDA is now -2510.74% below its all-time high of -$1.01 million, reached on June 30, 2020.
Performance
BTTX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
BTTX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +8.2% | +56.3% | +35.5% |
| 3 y3 years | -523.3% | +17.6% | -309.1% |
| 5 y5 years | -523.3% | -343.4% | -2510.7% |
BTTX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +8.2% | at high | +65.8% | at high | +38.0% |
| 5 y | 5-year | -523.3% | +8.2% | -343.4% | +65.8% | -2510.7% | +38.0% |
| alltime | all time | -523.3% | +8.2% | -343.4% | +65.8% | -2510.7% | +38.0% |
Better Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$4.50 M(-27.7%) | -$26.50 M(-18.0%) |
| Jun 2023 | - | -$6.23 M(-23.8%) | -$32.30 M(-7.8%) |
| Mar 2023 | - | -$8.17 M(+7.5%) | -$35.02 M(-1.4%) |
| Dec 2022 | -$35.53 M(-8.1%) | -$7.60 M(-26.2%) | -$35.53 M(-13.5%) |
| Sep 2022 | - | -$10.30 M(+15.1%) | -$41.10 M(-3.8%) |
| Jun 2022 | - | -$8.95 M(+3.1%) | -$42.73 M(+2.0%) |
| Mar 2022 | - | -$8.68 M(-34.0%) | -$41.90 M(+8.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$38.68 M(+538.5%) | -$13.16 M(+10.3%) | -$38.68 M(+51.6%) |
| Sep 2021 | - | -$11.94 M(+46.9%) | -$25.52 M(+87.9%) |
| Jun 2021 | - | -$8.12 M(+48.7%) | -$13.59 M(+109.7%) |
| Mar 2021 | - | -$5.46 M(+438.2%) | -$6.48 M(+538.2%) |
| Dec 2020 | -$6.06 M(+6.3%) | - | - |
| Jun 2020 | - | -$1.01 M | -$1.01 M |
| Dec 2019 | -$5.70 M | - | - |
FAQ
- What is Better Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Better Therapeutics?
- What is Better Therapeutics annual EBITDA year-on-year change?
- What is Better Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Better Therapeutics?
- What is Better Therapeutics quarterly EBITDA year-on-year change?
- What is Better Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Better Therapeutics?
- What is Better Therapeutics TTM EBITDA year-on-year change?
What is Better Therapeutics annual EBITDA?
The current annual EBITDA of BTTX is -$35.53 M
What is the all time high annual EBITDA for Better Therapeutics?
Better Therapeutics all-time high annual EBITDA is -$5.70 M
What is Better Therapeutics annual EBITDA year-on-year change?
Over the past year, BTTX annual EBITDA has changed by +$3.15 M (+8.15%)
What is Better Therapeutics quarterly EBITDA?
The current quarterly EBITDA of BTTX is -$4.50 M
What is the all time high quarterly EBITDA for Better Therapeutics?
Better Therapeutics all-time high quarterly EBITDA is -$1.01 M
What is Better Therapeutics quarterly EBITDA year-on-year change?
Over the past year, BTTX quarterly EBITDA has changed by +$5.80 M (+56.32%)
What is Better Therapeutics TTM EBITDA?
The current TTM EBITDA of BTTX is -$26.50 M
What is the all time high TTM EBITDA for Better Therapeutics?
Better Therapeutics all-time high TTM EBITDA is -$1.01 M
What is Better Therapeutics TTM EBITDA year-on-year change?
Over the past year, BTTX TTM EBITDA has changed by +$14.60 M (+35.52%)